Breaking News

REPORT: Biopharma Mfg. Capacity and Production

222 biopharma companies surveyed plus130 industry vendors and direct suppliers of materials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The 2108 15th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is available from BioPlan Associates. It is the most recent study of biotherapeutic developers and contract manufacturing organizations’ current and projected future capacity and production.

The report includes 15 years of biopharma trends analysis, reviews current opportunities and offers in-depth coverage of critical issues affecting the industry.

Coverage includes:
• Biosimilars pipeline in development
• In-depth analysis of key data, capacity, production trends, and benchmarks
• Budget trends and impact of current economic environment
• Expression system advances
• Downstream purification problems and issues
• Current and projected industry bottlenecks
• Capacity utilization and current production levels
• How capacity bottlenecks are being resolved
• Production trends and implications for industry
• Outsourcing trends
• International offshoring through 2023
• Disposables: Compare innovators vs CMOs & US vs Europe
• Batch failure rates & trends
• Selecting a CMO – Problems & solutions
• Quality management & PAT implementation

For information on purchasing a subscription to the 15th Annual Report, contact Donnie E. Gillespie at +1 (301) 841-7578, or click here.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters